This weekend, the Centers for Disease Control and Prevention confirmed more U.S. cases of the latest international outbreak – coronavirus – which started in Wuhan, China. Josh Michaud, an Associate Director for Global Health Policy at KFF, offers perspective on the U.S. role and how response to this outbreak compares to others, such as SARS and the Ebola epidemic.
- view as grid
- view as list
Ask KFF: MaryBeth Musumeci Answers 3 Questions on Kentucky, Arkansas Medicaid Work and Reporting Requirement Cases
A federal district court has set aside the HHS Secretary’s approval of Medicaid waivers with work and reporting requirements and other eligibility and enrollment restrictions in Kentucky and Arkansas. For context as this all develops, we asked MaryBeth Musumeci, Associate Director at the Program on Medicaid and the Uninsured, three questions about the implications of the decisions.
Karen Pollitz, senior fellow for health reform and private insurance at KFF, answers three questions about denied claims and how the federal government may change the data insurers are required to report on this issue.
Ask KFF: Alina Salganicoff Answers 3 Questions on Final Title X Regulations for Family Planning Clinics
In light of the new final rule regarding use of Title X federal funds for family planning clinics, Alina Salganicoff, Vice President and Director of Women’s Health Policy at KFF, answers three questions about their impact on women and the clinics that treat them.
Following President Trump’s Feb. 5 State of the Union announcement of a commitment to end HIV in the United States by 2030, KFF’s Tina Hoff answers three questions about HIV in America today and lessons learned through KFF’s Greater Than AIDS campaigns.
Larry Levitt Answers 3 Questions on Calif. Governor’s Proposed Individual Mandate, Expanded Subsidies
California Gov. Gavin Newsom announced broad plans to the state’s health care system almost immediately after taking the oath of office. Larry Levitt, Senior Vice President for Health Reform at KFF, answers three questions about what the plan’s individual mandate and expanded subsidies could mean for the state and nationwide.
Karen Pollitz answers three questions on the Trump administration’s recent changes to the ACA Section 1332 state innovation waiver guidelines and the implications for consumers and state marketplaces in our new “Ask KFF” feature.